Alexandria Picks Holobiome For First Seed Funding Investment
Zacks Investment Research | Apr 11, 2019 07:58AM ET
Alexandria Real Estate Equities, Inc. (NYSE:ARE) has made its first seed funding investment in Cambridge-based Holobiome, Inc., under the company’s recently-launched Alexandria Seed Capital Platform.
In fact, the company is celebrating the inaugural member class of seed- and early-stage life science firms associated with its life-science start-up platform, Alexandria LaunchLabs. The platform opened its first location at Alexandria Center in One Kendall Square (NYSE:SQ), Cambridge.
The 20,000-square-foot seed- and early-stage incubator, which opened last December, is currently home to 13 innovative member companies. At this life-science cluster, Alexandria provides flexible, cost-effective, move-in ready and well-equipped wet laboratory and office space. Further, it offers high-quality equipment and services, mentorship and programming, in addition to seed-capital access through Alexandria Seed Capital Platform, which is led by its venture capital business — Alexandria Venture Investments.
Impressively, on account of its efficient and responsible design, as well as construction practices Alexandria LaunchLabs – Cambridge is a LEED Gold certified campus. In addition, it achieved a Fitwel 3 Star Rating, demonstrating its ability to drive higher levels of member health, wellness and productivity.
Additionally, Alexandria has announced a call for applications for two Alexandria LaunchLabs Innovation Prizes, worth $125,000. This will recognize excellence in early-stage science, leadership and business strategy. The first prize is open for Massachusetts-based life-science entrepreneurs, and the second one will be awarded to academic spinouts nominated by local technology transfer offices. Entries will be accepted until May 31 and winners will be announced in June. The winners will receive $100,000 for research and development support. They will occupy office/laboratory space at Alexandria LaunchLabs – Cambridge for a year, worth an additional $25,000.
Such efforts come as part of the company’s expansion efforts to bank on the life-science real estate industry’s favorable fundamentals.
This Zacks #2 (Buy) Ranked stock has gained 19.5% over the past three months, outperforming 11.5% growth recorded by the Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.